Refresh

SHILPA MEDICARE LTD. - Intimation U/R 30.


Download
19 Nov 2021
Shilpa Medicare Limited, Unit III R&D facility clears US FDA Remote Record Review with no observations.

Source: BSE India

View all announcements for SHILPA MEDICARE LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com